Giovanni Brandimarte

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Antonio Tursi, Giovanni Brandimarte, Alfredo Papa et al. · The American Journal of Gastroenterology · 2010 · 491 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti et al. · PubMed · 2004 · 241 citations

Medicine, Pharmacology, Pharmacotherapy +10

High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal

Antonio Tursi, Giovanni Brandimarte, GianMarco Giorgetti · The American Journal of Gastroenterology · 2003 · 185 citations

Medicine, Internal Medicine, Nutrition +16

Prevalence of Antitissue Transglutaminase Antibodies in Different Degrees of Intestinal Damage in Celiac Disease

Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti · Journal of Clinical Gastroenterology · 2003 · 171 citations

Medicine, Internal Medicine, Pathology +17

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study

Antonio Tursi, Giovanni Brandimarte, Walter Elisei et al. · Alimentary Pharmacology & Therapeutics · 2013 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16